Lenalidomide contains not less than 98.0% and not more than 102.0% of C13H13N3O3, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

來那度胺
Lenalidomide

• 申請商: 宇直泰貿易股份有限公司
• 適應症: 抗癌藥原料藥
• 發證日期: 2018-12-12